Opera News

Opera News App

Not Again! South Africa Set To Receive J&J Vaccine Next Week, But There's a Problem...

By Daily-Perspectives | self meida writer
Published 16 days ago - 3597 views

Date: 10/02/21



After the whole blunder with the vaccines received from India, South Africans have been very sceptical about the whole issue of vaccines procurement. The health minister of South Africa Dr Zweli Mkhize and the President of South Africa were supposed to make sure that the vaccines that are brought into the country are in the rate state and are effective against the vigilant of the virus found in the country.

The Indian vaccine not only was a bad decision as it was found to only be 22.2% effective against the South African strain of the virus, but it was also found to be expiring on just 2 months time. While the country tried to out that blunder behind us, there is news that more of these vaccines are coming to the country. The health minister announced that the Johnson & Johnson vaccine is currently on its way to South Africa and will be arriving next week. This news seemed good at first, but there was a problem.

Vaccines are supposed to offer a country a fighting chance against the current pandemic. This means that the efficacy of the vaccine needs to be high enough to create herd immunity when used. It turns out that the Johnson and Johnson vaccine does not quite have an efficacy high enough to be trusted by many South Africans. This is because all these vaccines were created outside the country and never took into consideration the variant we have in South Africa.

The vaccine is 57% effective against the Covid-19 variant found in South Africa. This is quite a bigger number with reference to the Indian vaccine, but South Africans feel like it is not enough. Most countries have their vaccine well above 70% effective on the strain of the virus they currently have. This then offers a higher chance of getting heard immunity if the people are vaccinated. This new vaccine is categorised as "not good enough" by most South Africans.

There are already 2 different types of vaccines in South Africa and none of them are effective enough. They plan to use all of them in the people of South Africa. The Indian vaccine found to be effective 22.2% of the time will be given to the healthier people as it is said they might prevent the most severe form of the virus In South Africa. The issue of the vaccines is a very confusing one to say the least, there is no total security that they will work but hope that a difference will be made.

The only way to fight off all these problems of the buying of vaccines elsewhere is to produce these vaccines in the country. This will scientist to focus on the strain the country has and then improve it from thereon.

What is your take in the matter? Do you think 57% efficacy is good enough for South Africa?

Leave a comment below and please follow me for more insightful news reporting.

Content created and supplied by: Daily-Perspectives (via Opera News )


Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform



View all comments